Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Anemia
Related studies linked through entity extraction aliases.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
- Status
- COMPLETED
- Phase
- PHASE3
The Israeli Trigger for Blood Transfusions in the ICU
- Status
- UNKNOWN
- Phase
- N/A
A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)
- Status
- COMPLETED
- Phase
- PHASE4
Darbepoetin Alfa With or Without Intravenous (IV) Iron
- Status
- COMPLETED
- Phase
- PHASE2
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
- Status
- COMPLETED
- Phase
- PHASE3
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)
- Status
- COMPLETED
- Phase
- N/A
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia
- Status
- COMPLETED
- Phase
- PHASE3
Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study
- Status
- COMPLETED
- Phase
- N/A
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients
- Status
- COMPLETED
- Phase
- PHASE3
Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.
- Status
- COMPLETED
- Phase
- NA
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
- Status
- WITHDRAWN
- Phase
- PHASE3
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
- Status
- COMPLETED
- Phase
- N/A
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3